School receives $8 million grant to study asthma, allergies
Researchers at Washington University School of Medicine in St. Louis, including Michael Holtzman, MD, have received an $8 million grant from the National Institutes of Health to study the role of the barrier functions of the skin, gut, and airway in asthma and allergic diseases. Understanding the role of the epithelial cells in these tissues may help prevent and treat respiratory illnesses in the future, the researchers say.
Drug may slow spread of deadly eye cancer
A drug commonly used to treat seizures appears to make eye tumors less likely to grow if they spread to other parts of the body, according to new research at the School of Medicine. Their findings are available online in the journal Clinical Cancer Research.
Legal drinking age linked to women’s suicide, homicide risk
New research by Richard Grucza, PhD, at Washington University School of Medicine in St. Louis shows that a legal drinking age of less than 21 is linked to a higher risk of homicides and suicides among adult women.
Introducing new faculty members
The following are among the new faculty members at Washington University: Joseph Cullen, PhD; Amr Farahat, PhD; Exequiel Hernández, PhD; Baojun Jiang, PhD; Ping C. Lieser, PhD; Asaf Manela, PhD; Matthew Ringgenberg, PhD; and Adina Sterling, PhD. Others will be introduced periodically.
Massoumzadeh participates in U.S. women’s study tour of Brazil
Parinaz Massoumzadeh, PhD, staff scientist in the Department of Radiology, was one of eight American women chosen to participate in a U.S.-Brazil exchange program to recruit, retain and advance women in science, technology, engineering and mathematics.
Researchers identify gene for rare dementia
Studying family members suspected of having Alzheimer’s disease, researchers at Washington University School of Medicine in St. Louis have identified a gene that causes a rare disorder highlighted by memory loss and motor impairments. The condition is known as Kufs disease, but scientists say the discovery paves the way to development of a genetic test for Kufs and to therapies to treat dementia, which is a hallmark of Kufs and of other neurodegenerative conditions, such as Alzheimer’s disease.
Daily wheezing treatment no different from intermittent in toddlers
Pediatricians often treat young children who have frequent bouts of wheezing with a daily dose of an inhaled steroid to keep asthma symptoms at bay. But results of a recent study by researchers at Washington University School of Medicine, including Leonard B. Bacharier, MD, are likely to change that.
Surprising pathway implicated in stuttering
Researchers at Washington University School of Medicine in St. Louis, including Stuart A. Kornfeld, MD, have obtained new evidence that at least some persistent stuttering is caused by mutations in a gene governing not speech, but a metabolic pathway involved in recycling old cell parts. Beyond a simple association, the study provides the first evidence that mutations affecting cellular recycling centers called lysosomes actually play a role in causing some people to stutter.
New service brings power of genomics to patient care
Genomics and Pathology Services at Washington University School of Medicine in St. Louis (GPS@WUSTL), directed by Karen Seibert, PhD, is now offering a test for mutations in 28 genes associated with cancer. The genes in the test affect a variety of different types of tumors, including blood, lymph, lung, brain, bladder, kidney, skin, stomach, prostate and breast cancers.
Human, artificial intelligence join forces to pinpoint fossil locations
Traditionally, fossil-hunters often could only make educated guesses as to where fossils lie. The rest lay with chance. But thanks to a software model used by WUSTL professor Glenn Conroy, PhD, and researchers at Western Michigan University, fossil-hunters’ reliance on luck when finding fossils may be diminishing. Using artificial neural networks, Conroy and colleagues developed a computer model that can pinpoint productive fossil sites.
View More Stories